ArticleInternational journal of women's health2026
Analysis of EBV Infection and Gene Integration in Cervical Exfoliated Cells from HPV-Positive Women.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of EBV Infection and Gene Integration in Cervical Exfoliated Cells from HPV-Positive Women.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Epstein-Barr virus (EBV) infection and gene integration have been detected in cervical cancer tissues, but the association between the two has not yet been confirmed. This study employed a high-throughput viral integration detection method to analyze EBV infection and integration status in cervical exfoliated cells from 88 HPV-positive women, investigating whether a correlation exists between the two. Patients and Methods: Cervical exfoliated cell samples from 88 HPV-positive female patients were obtained from the Cancer Hospital Affiliated to Xinjiang Medical University. Liquid-based cytology was diagnosed by hospital pathologists, followed by high-throughput detection to evaluate EBV and HPV infection and integration. Results: We found that EBV was detected in 34.09% (30/88) of cervical exfoliated cells from HPV-positive females. The EBV positivity rate was 31.65% (25/79) in cases with multiple HPV infections and 55.56% (5/9) in those with single HPV subtype infection. The EBV infection rate in samples with HPV16/18 subtype infection was 41.86% (18/43), while in samples without HPV16/18 subtype infection, the EBV infection rate was 26.67% (12/45). According to the 2019 guidelines of the American Society for Colposcopy and Cervical Pathology (ASCCP), based on the risk of developing CIN III or higher lesions within five years, the EBV infection rates were 25.93% (7/27) in the normal group, 32.35% (11/34) in the low-risk group, and 44.44% (12/27) in the high-risk group. The most common sites for EBV self-integration occur within protein-coding regions, while integrations at repetitive sequences are relatively rare. In cases of HPV and EBV co-infection, HPV and EBV exhibit correlations in integration events and the distribution of integrated genes on host chromosomes. Under high-risk conditions, the number of EBV integrations, the genes involved in integration, and differentially expressed genes all exhibit significant differences. Conclusion: EBV potentially contributes to cervical cancer progression, and additional research and experimental verification are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.